Keywords: basilea/j, ceftobiprole, approved, canada, basilea, pharmaceutica, zeftera

Basilea/J&J's ceftobiprole approved in Canada

Article | 07 July 2008

Basilea Pharmaceutica's ceftobiprole (Zeftera) has been approved by Health Canada for the treatment of complicated skin and soft tissue infections ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Johnson & Johnson

Go to company listing